| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.45 | 0.01 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |